Cellbxhealth PLC
ANPCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $37,944 | $30,308 | $105,999 | $275,099 |
| - Cash | $10,425 | $16,218 | $31,896 | $31,839 |
| + Debt | $4,210 | $4,554 | $5,001 | $2,338 |
| Enterprise Value | $31,729 | $18,644 | $79,104 | $245,598 |
| Revenue | $2,862 | $2,186 | $1,041 | $1,013 |
| % Growth | 30.9% | 110% | 2.8% | – |
| Gross Profit | $1,779 | -$408 | $613 | $711 |
| % Margin | 62.2% | -18.7% | 58.9% | 70.2% |
| EBITDA | -$13,024 | -$18,999 | -$24,387 | -$15,719 |
| % Margin | -455.1% | -869.1% | -2,342.7% | -1,551.7% |
| Net Income | -$14,225 | -$20,132 | -$21,686 | -$15,012 |
| % Margin | -497% | -921% | -2,083.2% | -1,481.9% |
| EPS Diluted | -0.048 | -0.077 | -0.088 | -0.067 |
| % Growth | 37.6% | 12.1% | -31.8% | – |
| Operating Cash Flow | -$13,448 | -$14,458 | -$16,050 | -$14,010 |
| Capital Expenditures | -$444 | -$660 | -$1,887 | -$1,788 |
| Free Cash Flow | -$13,892 | -$15,118 | -$17,937 | -$15,798 |